BACKGROUND: Microaspiration is a major factor in ventilator-associated pneumonia (VAP) pathophysiology. Subglottic secretion drainage (SSD) aims at reducing its incidence. METHODS: Single-center prospective observational study, performed in a French intensive care unit (ICU) from March 2012 to April 2013, including adult patients mechanically ventilated for at least 24 hours divided in two groups: patients in the SSD group intubated using tracheal tubes allowing SSD and patients in the control group intubated with standard tracheal tubes. Pepsin and salivary amylase concentrations were measured for 24 hours in all tracheal aspirates. Primary objective was to determine the impact of SSD on gastric or oropharyngeal microaspiration using pepsin or amylase concentration in tracheal aspirates. RESULTS: Fifty-five patients were included in the SSD group and 45 in the control group. No difference was found between groups regarding the incidence of microaspiration defined as at least one tracheal aspirate positive for either pepsin or amylase [49 (89%) vs. 37 (82%), P=0.469]. Percentage of patients with VAP [16 (29%) vs. 11 (24%), P=0.656], ventilator-associated tracheobronchitis (VAT) [7 (13%) vs. 4 (9%), P=0.750] or early airway colonization [15 (35%) vs. 8 (18%), P=0.219] were not significantly different in study groups. CONCLUSIONS: SSD did not reduce the incidence of microaspiration, VAP, VAT or airway colonization in this observational study.
BACKGROUND: Microaspiration is a major factor in ventilator-associated pneumonia (VAP) pathophysiology. Subglottic secretion drainage (SSD) aims at reducing its incidence. METHODS: Single-center prospective observational study, performed in a French intensive care unit (ICU) from March 2012 to April 2013, including adult patients mechanically ventilated for at least 24 hours divided in two groups: patients in the SSD group intubated using tracheal tubes allowing SSD and patients in the control group intubated with standard tracheal tubes. Pepsin and salivary amylase concentrations were measured for 24 hours in all tracheal aspirates. Primary objective was to determine the impact of SSD on gastric or oropharyngeal microaspiration using pepsin or amylase concentration in tracheal aspirates. RESULTS: Fifty-five patients were included in the SSD group and 45 in the control group. No difference was found between groups regarding the incidence of microaspiration defined as at least one tracheal aspirate positive for either pepsin or amylase [49 (89%) vs. 37 (82%), P=0.469]. Percentage of patients with VAP [16 (29%) vs. 11 (24%), P=0.656], ventilator-associated tracheobronchitis (VAT) [7 (13%) vs. 4 (9%), P=0.750] or early airway colonization [15 (35%) vs. 8 (18%), P=0.219] were not significantly different in study groups. CONCLUSIONS: SSD did not reduce the incidence of microaspiration, VAP, VAT or airway colonization in this observational study.
Authors: Cameron Dezfulian; Kaveh Shojania; Harold R Collard; H Myra Kim; Michael A Matthay; Sanjay Saint Journal: Am J Med Date: 2005-01 Impact factor: 4.965
Authors: P Mahul; C Auboyer; R Jospe; A Ros; C Guerin; Z el Khouri; M Galliez; A Dumont; O Gaudin Journal: Intensive Care Med Date: 1992 Impact factor: 17.440
Authors: Jean-Claude Lacherade; Bernard De Jonghe; Pierre Guezennec; Karim Debbat; Jan Hayon; Antoine Monsel; Pascal Fangio; Corinne Appere de Vecchi; Cédric Ramaut; Hervé Outin; Sylvie Bastuji-Garin Journal: Am J Respir Crit Care Med Date: 2010-06-03 Impact factor: 21.405
Authors: Ahmed M Abd El-Fattah; Gamal A Abdul Maksoud; Ahmed S Ramadan; Ahmed F Abdalla; Mohamed M Abdel Aziz Journal: Otolaryngol Head Neck Surg Date: 2007-03 Impact factor: 3.497
Authors: Steven Talbert; Christine Wargo Detrick; Kimberly Emery; Aurea Middleton; Bassam Abomoelak; Chirajyoti Deb; Devendra I Mehta; Mary Lou Sole Journal: Am J Crit Care Date: 2020-09-01 Impact factor: 2.228